BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Oncogene

• Publication date

  1996-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8895509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen and progestin effects in human breast carcinogenesis

  2004cited by this paper
• Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families

  1996cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

  1996cited by this paper
• BRCA1 mutations in a population-based sample of young women with breast cancer.

  1996cited by this paper
• BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

  1996cited by this paper
• Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.

  1995cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.

  1995cited by this paper
• Hormone-dependent regulation of BRCA1 in human breast cancer cells.

  1995cited by this paper
• Defects of androgen receptor function: from sex reversal to motor neurone disease.

  1995cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.

  1995cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Male breast cancer.

  1994cited by this paper
• Progestins and antiprogestins in mammary tumour growth and metastasis.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Proliferation indices of invasive breast carcinomas after in vivo 5‐bromo‐2′‐deoxyuridine labelling: A flow cytometric study of 75 tumours

  1992cited by this paper
• Abnormal estrogen receptor in clinical breast cancer.

  1992cited by this paper
• A potent specific pure antiestrogen with clinical potential.

  1991cited by this paper
• Progestin regulation of cellular proliferation.

  1990cited by this paper
• Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens.

  1990cited by this paper
• Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.

  1987cited by this paper
• Estrogen and oncogene mediated growth regulation of human breast cancer cells.

  1987cited by this paper
• A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle

  1986cited by this paper
• Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells.

  1986cited by this paper
• Breast Development in Puberty

  1986cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

  1982cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Isolation of two human tumor epithelial cell lines from solid breast carcinomas.

  1978cited by this paper
• Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

  1978cited by this paper

• In vivo investigation of STN1 downregulation in melanoma formation in adult mice following UV irradiation

  2025cites this paper
• Human Cancers Derived from Either Genetic or Lifestyle Factors Are Initiated by Impaired Estrogen Signaling

  2025cites this paper
• Genome-wide mapping and quantification of DNA damage induced by catechol estrogens using Click-Probe-Seq and LC-MS2

  2025cites this paper
• DNA Damage Responses in Tumors Are Not Proliferative Stimuli, but Rather They Are DNA Repair Actions Requiring Supportive Medical Care

  2024cites this paper
• Histological and molecular difference in albumen quality between post-adolescent hens and aged hens

  2024cites this paper
• Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

  2023cites this paper
• Estrogen and DNA damage modulate mRNA levels of genes involved in homologous recombination repair in estrogen-deprived cells

  2022cites this paper
• The effects of estrogen on targeted cancer therapy drugs.

  2022cites this paper
• The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen

  2022cites this paper
• Proteomic profile alterations inporcine conceptuses during early stages of development.

  2021cites this paper
• BRCA2 represses the transcriptional activity of pS2 by E2-ERα.

  2021cites this paper
• Compensatory Estrogen Signal Is Capable of DNA Repair in Antiestrogen-Responsive Cancer Cells via Activating Mutations

  2020cites this paper
• A molecular basis for Estrogen Receptor- α deficiency in BRCA1-linked breast cancer

  2019cites this paper
• The molecular basis of cytotoxicity of α‐spinasterol from Ganoderma resinaceum: Induction of apoptosis and overexpression of p53 in breast and ovarian cancer cell lines

  2018cites this paper
• BRCA1-Dependent Transcriptional Regulation: Implication in Tissue-Specific Tumor Suppression

  2018cites this paper
• Assessment of the expression of the BRCA1, BRCA2, TP53, MDM2, BAX and CASP-3 genes in normal and tumor tissues for patients with breast cancer in Morocco

  2018cites this paper
• Studies of Breast Cancer Chemoprevention in Human High-Risk Primary Cells and Genetically Engineered Mouse Models

  2018cites this paper
• Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer

  2018cites this paper
• H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes.

  2016cites this paper
• Structure activity relationship studies on cytotoxicity and the effects on steroid receptors of AB-functionalized cholestanes

  2016cites this paper
• Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management

  2016cites this paper
• The Microenvironment of Lung Cancer and Therapeutic Implications.

  2016cites this paper
• Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond.

  2016cites this paper
• Alteration of BRCA1 expression affects alcohol-induced transcription of RNA Pol III-dependent genes.

  2015cites this paper
• DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers

  2015cites this paper
• Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers

  2014influential citation
• BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?

  2014cites this paper
• Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development

  2014cites this paper
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2014cites this paper
• The Immunoendocrine Network in Breast Cancer

  2014cites this paper
• Derailed estrogen signaling and breast cancer: an authentic couple.

  2013cites this paper
• The Identification and Characterization of Stem/Progenitor Cells in the Ovarian Surface Epithelium

  2013cites this paper
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2013cites this paper
• Determinants of cell cycle progression in human mammary epithelial MCF12 cells

  2012cites this paper
• Nuevos blancos moleculares en el cáncer de próstata

  2012cites this paper
• Interference with Estrogen Receptor-α by Dietary Components: Impact on the Balance Between Cell Proliferation and Cell Death

  2012cites this paper
• POTENTIAL OF MARINE DERIVED COMPOUNDS AGAINST BREAST CANCER (BRCA1): AN IN - SILICO DOCKING STUDY

  2012cites this paper
• BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer

  2011influential citation
• Regulation of the BRCA1 gene by an SRC3/53BP1 complex

  2011cites this paper
• The impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications

  2011cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene

  2011cites this paper
• Transcriptional regulation of BRCA1 expression by a metabolic switch

  2010cites this paper
• AKT regulates BRCA1 stability in response to hormone signaling.

  2010cites this paper
• UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer

  2010cites this paper
• Genetics and Breast Cancer Risk

  2010cites this paper
• Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat mammary tumorigenesis.

  2009cites this paper
• The Complex Relationship between BRCA1 and ERα in Hereditary Breast Cancer

  2009cites this paper
• The Complex Relationship between BRCA 1 and ER A in Hereditary Breast Cancer

  2009cites this paper
• Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

  2009cites this paper
• Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene

  2008cites this paper
• BRCA1, Hormone, and Tissue-Specific Tumor Suppression

  2008cites this paper
• Estrogen Receptor (ER) β or p53 Attenuates ERα-mediated Transcriptional Activation on the BRCA2 Promoter*

  2008cites this paper
• Progesterone receptor action: translating studies in breast cancer models to clinical insights.

  2008cites this paper
• Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brcal, Brca2,

  2007cites this paper
• Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro.

  2007cites this paper
• Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer

  2007cites this paper
• MOLECULAR STRESS SIGNALING IN BREAST EPITHELIAL CELLS Characterization of the Regulation of the Breast Cancer Susceptibility Gene 1 (BRCA1) by Stress Signaling and Design of an Epidemiological Study Examining the Effect of Glucocorticoid Receptor Genetic Variants on Breast Cancer Risk

  2007cites this paper
• Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues.

  2007cites this paper
• Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

  2007cites this paper
• Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine

  2007cites this paper
• Soya phytonutrients act on a panel of genes implicated with BRCA1and BRCA2 oncosuppressors in human breast cell lines

  2006cites this paper
• Endocrine disruptor contaminants in water and their adverse effects in humans

  2006cites this paper
• Hormonal activation of genes through nongenomic pathways by estrogen and structurally diverse estrogenic compounds

  2006cites this paper
• The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers

  2006cites this paper
• Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of Zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers

  2006cites this paper
• GENETICKÁ PREDISPOZICE KE VZNIKU MALIGNÍHO NÁDORU PRSU GENETIC SUSCEPTIBILITY TO BREAST CANCER

  2006cites this paper
• A Molecular Model For Transcriptional Regulation of BRCA-1 Expression

  2005cites this paper
• The “portrait” of hereditary breast cancer

  2005influential citation
• Is BRCA1/BRCA2‐related breast carcinogenesis estrogen dependent?

  2005cites this paper
• Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line.

  2005cites this paper
• An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.

  2005cites this paper
• 2 The ‘ ‘ portrait ’ ’ of hereditary breast cancer 3

  2004cites this paper
• Nutritional modulation of the cell cycle and breast cancer.

  2004cites this paper
• Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers

  2004cites this paper
• Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines.

  2004cites this paper
• Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor A

  2004cites this paper
• Problèmes posés par la prise en charge gynécologique des femmes porteuses d’une mutation germinale des gènes BRCA 1 & 2

  2003cites this paper
• BRCA1 gene in breast cancer

  2003cites this paper
• Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis.

  2003cites this paper
• Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray

  2003cites this paper
• Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats.

  2003influential citation
• BRCA1 and Estrogen Signaling in Breast Cancer

  2003cites this paper
• Effects of the Phytoestrogens Genistein and Daidzein on BRCA2 Tumor Suppressor Gene Expression in Breast Cell Lines

  2003influential citation
• Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias.

  2003cites this paper
• [Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations].

  2003cites this paper
• Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines

  2003cites this paper
• Novel consensus DNA‐binding sequence for BRCA1 protein complexes

  2003cites this paper
• Regulation of BRCA1 expression and its relationship to sporadic breast cancer

  2002cites this paper
• Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: requirements for metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.

  2002cites this paper
• Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor kappaB/CCAAT-binding transcription factor-1 complex.

  2002cites this paper
• Brca1 and differentiation.

  2002cites this paper
• The Breast Cancer Phenotype and Endocrine Response: Implications for New Drug Development Initiatives

  2002cites this paper
• BRCA1 regulates the interferon gamma-mediated apoptotic response.

  2002cites this paper
• BRCA-1, BRCA-2 and Hereditary Breast Cancer

  2002cites this paper
• BRCA2 Monoclonal Antibodies React with Differentiating Epithelium

  2002cites this paper
• Germline mutations of BRCA1 and BRCA2 genes - founder effects and contribution to ovarian carcinoma in Finland

  2002cites this paper
• Breast cancer-predisposing genes in Finnish breast and ovarian cancer families

  2001cites this paper
• BRCA1 and Prostate Cancer

  2001cites this paper
• Implication of BRCAl gene in breast cancer

  2001cites this paper